Literature DB >> 7623160

D1 receptors modulate glutamate transmission in the ventral tegmental area.

P W Kalivas1, P Duffy.   

Abstract

Perfusion of the D1 agonist, SKF-82958, through a microdialysis probe implanted in the ventral tegmental area produced a dose-dependent increase in extracellular glutamate and GABA. The increase in extracellular glutamate occurred at approximately 30x lower dose than the elevation in GABA. The increase in extracellular glutamate by SKF-82958 was blocked by coperfusion of the D1 antagonist, SCH-23390, and was not mimicked by perfusion of the D2/3 agonist, quinpirole, into the ventral tegmental area. In contrast, the elevation in extracellular GABA was insensitive to blockade by SCH-23390. Systemic administration of cocaine (15 mg/kg, i.p.) produced a rapid elevation in extracellular glutamate lasting for 20 min that was prevented by pretreating the ventral tegmental area with SCH-23390. In contrast, acute cocaine produced a reduction in extracellular GABA content in the ventral tegmental area that was not affected by SCH-23390. These data indicate that the stimulation of D1 receptors in the ventral tegmental area increases the release of glutamate and that increasing extracellular levels of somatodendritic dopamine by systemic cocaine can mimic this effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623160      PMCID: PMC6577867     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.

Authors:  R Ranaldi; R A Wise
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

2.  Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

Review 3.  Pregnane xenobiotic receptors and membrane progestin receptors: role in neurosteroid-mediated motivated behaviours.

Authors:  C A Frye; C J Koonce; A A Walf
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

4.  The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.

Authors:  Neil E Paterson; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

5.  Spontaneous transmitter release is critical for the induction of long-term and intermediate-term facilitation in Aplysia.

Authors:  Iksung Jin; Sathya Puthanveettil; Hiroshi Udo; Kevin Karl; Eric R Kandel; Robert D Hawkins
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

6.  Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction.

Authors:  Roy A Wise
Journal:  Trends Neurosci       Date:  2009-09-14       Impact factor: 13.837

7.  Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.

Authors:  Tanya L Daigle; Mark J Ferris; Raul R Gainetdinov; Tatyana D Sotnikova; Nikhil M Urs; Sara R Jones; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2014-04-29       Impact factor: 7.853

8.  Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Authors:  Elena H Chartoff; Matthew F Barhight; Steve D Mague; Allison M Sawyer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

Review 9.  Illicit dopamine transients: reconciling actions of abused drugs.

Authors:  Dan P Covey; Mitchell F Roitman; Paul A Garris
Journal:  Trends Neurosci       Date:  2014-03-20       Impact factor: 13.837

Review 10.  Membrane actions of progestins at dopamine type 1-like and GABAA receptors involve downstream signal transduction pathways.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Steroids       Date:  2008-02-08       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.